When Aakash, a 28-year-old with type-2 diabetes, started taking Mounjaro earlier this year, his life changed dramatically. The drug, a GLP-1 (glucagon-like peptide-1) injection, quicklyView More
PATHFINDERS TRAININGS
unlocking your potential
When Aakash, a 28-year-old with type-2 diabetes, started taking Mounjaro earlier this year, his life changed dramatically. The drug, a GLP-1 (glucagon-like peptide-1) injection, quicklyView More